Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2026)
Scinai Immunotherapeutics (SCNI) reported Change in Receivables of -$22000.0 for Q1 2026, down 146.81% on a YoY basis from $47000.0 in Q1 2025, and up 68.57% sequentially from -$70000.0 in Q2 2025.
Scinai Immunotherapeutics (SCNI) Change in Receivables (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 8 years of Change in Receivables data on file, last reported at -$22000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 146.81% year-over-year to -$22000.0; the trailing twelve-month figure through Mar 2026 stood at -$71000.0 (down 273.68% YoY), and the FY2025 full-year result was -$10000.0, down 112.05% from the prior year.
- Change in Receivables improved to -$22000.0 in Q1 2026, from -$70000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $372000.0 in Q4 2023 to a low of -$132000.0 in Q2 2023.
- A 4-year average of $29818.2 and a median of -$22000.0 in 2026 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables surged 98.89% in 2024 and plunged 146.81% in 2026, its largest moves.
- Tracing SCNI's Change in Receivables over 4 years: stood at $372000.0 in 2023, then plunged by 106.99% to -$26000.0 in 2024, then plunged by 169.23% to -$70000.0 in 2025, then soared by 68.57% to -$22000.0 in 2026.
- Business Quant data shows SCNI's Change in Receivables at -$22000.0 in Q1 2026, -$70000.0 in Q2 2025, and $47000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | -22,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Jun 30, 2025 | -70,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Jun 30, 2024 | -39,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Dec 31, 2023 | 372,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Sep 30, 2023 | -90,000.00 |
| Jun 30, 2023 | -132,000.00 |
| Jun 30, 2023 | -132,000.00 |